COMMUNIQUÉS West-GlobeNewswire

Clinical Genomics is proud to support Strides for Life and Super Bowel I
24/08/2018
Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I BRIDGEWATER, N.J., Aug. 24, 2018 (GLOBE NEWSWIRE [...]
Solon Eiendom ASA – Major shareholding and primary insider notification
24/08/2018
(Oslo, Norway, August 24, 2018) Alden AS has today sold 6.044.556 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Owner of Alden AS, Edvin Austbø, is married to Solon Eiendom ASA Board Member Heidi [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
24/08/2018
FIT Biotech Oy Company release August 24, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema
24/08/2018
- ADVM-053 is a novel gene therapy candidate designed as a potential single‑administration treatment for hereditary angioedema (“HAE”) - Plans to submit an Investigational New Drug (IND) application to the FDA for ADVM- [...]
Hemispherx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
24/08/2018
ORLANDO, Fla., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, announced [...]
SHIRE ANNOUNCES CASH TENDER OFFERS FOR UP TO $2,250,000,000 OUTSTANDING PRINCIPAL AMOUNT OF NOTES
24/08/2018
SHIRE ANNOUNCES CASH TENDER OFFERS FOR UP TO $2,250,000,000 OUTSTANDING PRINCIPAL AMOUNT OF NOTES Dublin, Ireland – August 24, 2018 – Shire plc (LSE: SHP and NASDAQ: SHPG) (“Shire”), Baxalta Incorporated, a Delaware [...]
Daxor Corporation Announces a 23 Percent Rise in BVA-100 Kit Sales in the Area of Cardiology and Filing of Form N-CSR for June 30, 2018
24/08/2018
NEW YORK, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations filed a Form N-CSR disclosing its schedule of [...]
Federal Appeals Court Finds in Favor of Align and Vacates Patent Board’s Decision on ClearCorrect’s Challenge to Align Patent
24/08/2018
SAN JOSE, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that on August 22, 2018 the United States Court of Appeals for the Federal Circuit (“Federal Circuit”) vacated [...]
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
24/08/2018
THE SHAREHOLDERS OF OASMIA PHARMACEUTICAL AB ARE HEREBY GIVEN NOTICE OF THE ANNUAL GENERAL MEETING ON TUESDAY 25 SEPTEMBER 2018, AT 14:00 CET, AT THE OFFICES OF THE COMPANY, VALLONGATAN 1, 752 28 UPPSALA. THE [...]
American Cannabis Company, Inc. Comments on New Chief Financial Officer, Engagement of New Independent Auditor and SEC Filing Status
24/08/2018
DENVER, CO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary [...]
Emerald Health Therapeutics Engages Acorn Management Partners for Investor Relations
24/08/2018
VICTORIA, British Columbia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that it has engaged Acorn Management Partners, an Atlanta-based [...]
New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker
24/08/2018
A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications describing research on TK1 [...]
Announcement no. 6/2018 - Financial calendar 2018/19
24/08/2018
Please see enclosed pdf. Attachment 6-18 Financial Calendar 2018-19
Biohit Oyj: Managers' Transactions
24/08/2018
BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 At 14.30 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: [...]
Biohit Oyj: Managers' Transactions
24/08/2018
BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 At 14.30 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior Management Issuer [...]
Resonant Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
24/08/2018
GOLETA, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, is scheduled to [...]
R1 RCM to Present at the Baird 2018 Global Healthcare Conference
24/08/2018
CHICAGO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced its management team will [...]
RedHill Biopharma to Host Second Quarter 2018 Financial Results Conference Call on August 30, 2018
24/08/2018
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 24, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA
24/08/2018
Date on which the terms and conditions of the preferential rights issue were announced: 24 august 2018 Last day including right: 14 September 2018 Ex-date: 17 September 2018 Record Date: 18 September 2018 Date of [...]

Pages